(Abst.) Real-life persistence and tolerability w/Tecfidera on: June 16, 2018, 02:56:04 pm #1 From PubMed, June 16, 2018--"Real-life persistence and tolerability with dimethyl fumarate" from researchers in Denmark: Real-life persistence and tolerability with dimethyl fumarate - PubMed Adherence in real-life was similar to pivotal trials. Differences in discontinuation rates at two MS clinics underline importance of AE management. PubMed · ncbi.nlm.nih.gov Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
